Structure-activity and structure-property relationship studies of spirocyclic chromanes with antimalarial activity

Bioorg Med Chem. 2022 Mar 1:57:116629. doi: 10.1016/j.bmc.2022.116629. Epub 2022 Jan 14.

Abstract

Malaria is a prevalent and lethal disease. The fast emergence and spread of resistance to current therapies is a major concern and the development of a novel line of therapy that could overcome, the problem of drug resistance, is imperative. Screening of a set of compounds with drug/natural product-based sub-structural motifs led to the identification of spirocyclic chroman-4-one 1 with promising antimalarial activity against the chloroquine-resistant Dd2 and chloroquine-sensitive 3D7 strains of the parasite. Extensive structure-activity and structure-property relationship studies were conducted to identify the essential features necessary for its activity and properties.

Keywords: Antimalarial; Drug resistance; Natural products; Spirocyclic chromane; Structure-activity relationship; Structure-property relationship.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antimalarials / chemical synthesis
  • Antimalarials / chemistry
  • Antimalarials / pharmacology*
  • Cell Survival / drug effects
  • Chromans / chemical synthesis
  • Chromans / chemistry
  • Chromans / pharmacology*
  • Crystallography, X-Ray
  • Dose-Response Relationship, Drug
  • Hep G2 Cells
  • Humans
  • Malaria / drug therapy*
  • Models, Molecular
  • Molecular Structure
  • Parasitic Sensitivity Tests
  • Plasmodium / drug effects*
  • Spiro Compounds / chemical synthesis
  • Spiro Compounds / chemistry
  • Spiro Compounds / pharmacology*
  • Structure-Activity Relationship

Substances

  • Antimalarials
  • Chromans
  • Spiro Compounds